The legal action, filed by the Rosen Law Firm, centers on claims that Cogent executives provided misleading information regarding the firm's revenue and margin targets. According to the complaint, a significant portion of the company's purported optical wavelength backlog was unlikely to result in paid orders, as many customers were either unable or unwilling to accept delivery. These alleged misrepresentations reached a breaking point when the company's financial stability and dividend policy were called into question.
Furthermore, the lawsuit highlights concerns surrounding David Schaeffer, alleging that undisclosed risks related to his stock pledging activities threatened to depress share prices. Investors impacted by these disclosures have until September 21, 2026, to move the court to serve as a lead plaintiff. While a class has not yet been certified, those who purchased common stock during the specified period may be eligible for compensation through a contingency fee arrangement. Participation in future recoveries does not require an investor to serve as a lead plaintiff, and individuals retain the right to select their own legal representation.
Comments (0)
No comments yet. Be the first!